Bestaande gebruiker? Log in
Abonneren
Home
Beurs vandaag
Koersen
Nieuws
Agenda
Analisten
Analisten vandaag
Meest aanbevolen aandelen
Minst aanbevolen aandelen
Aandelen met grootste potentieel
Insider trading
Insiders vandaag
Meest gekochte aandelen
Meest verkochte aandelen
Mijn Trivano
Mijn Trivano
Mijn selecties
Abonneren
Beurs vandaag
Koersen
Nieuws
Agenda
Analisten
Insider trading
Mijn Trivano
Registreren / inloggen
Trivano
Alles over “Tandheelkundige laboratoria”
Aandelen in “Tandheelkundige laboratoria”
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
#
Aandeel
Datum
Koers
Evolutie
Even geduld...
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
#
Nieuws over “Tandheelkundige laboratoria”
Toon enkel gratis nieuws
12/03 ·
Quest Diagnostics Elects Timothy Wentworth, Former CEO of Walgreens Boots Alliance, Evernorth Health Services and Express Scripts, to Board of Directors
· Persbericht
12/03 ·
Quest Diagnostics Elects Timothy Wentworth, Former CEO of Walgreens Boots Alliance, Evernorth Health Services and Express Scripts, to Board of Directors
· Persbericht
2/03 ·
Quest Diagnostics Introduces AI Companion to Help Patients Understand and Act on Lab Test Results
· Persbericht
2/03 ·
RadNet Acquires Gleamer, Making RadNet’s DeepHealth the Largest Provider of Radiology Clinical AI Solutions Worldwide
· Persbericht
26/02 ·
Quest Diagnostics Names Benjamin Beauvalot Senior Vice President, Chief Strategy and M&A Officer
· Persbericht
25/02 ·
Quest Diagnostics to Speak at the Leerink 2026 Global Healthcare Conference
· Persbericht
23/02 ·
Labcorp Expands Collaboration with PathAI to Deploy FDA-Cleared Digital Pathology Platform Nationwide
· Persbericht
17/02 ·
Labcorp Announces 2025 Fourth Quarter and Full Year Results
· Persbericht
12/02 ·
Guardant Health Launches Community Colorectal Cancer Screening Grant Program in Recognition of CRC Awareness Month, Applications Now Open
· Persbericht
11/02 ·
Labcorp Launches First FDA-Cleared Blood Test for Alzheimer's Disease Assessment in Primary Care
· Persbericht
10/02 ·
Quest Diagnostics Reports Fourth Quarter and Full Year 2025 Financial Results; Provides Guidance for Full Year 2026; Increases Quarterly Dividend 7.5% to $0.86 Per Share
· Persbericht
10/02 ·
Quest Diagnostics Increases Dividend 7.5% To $0.86 Per Quarter, Marking 15 Consecutive Years of Dividend Increases; Announces $1 Billion Increase in Share Repurchase Authorization
· Persbericht
9/02 ·
Labcorp Appoints John H. Sampson, M.D., Ph.D., to Board of Directors
· Persbericht
2/02 ·
Quest Diagnostics Launches Novel Flow Cytometry MRD Blood Test for Myeloma, Enabling Ultrasensitive Detection of Residual Disease
· Persbericht
26/01 ·
PHSC Plc - Disposal of Freehold Property at Raunds
· Persbericht
21/01 ·
Quest Diagnostics Named to Fortune's World's Most Admired Companies List for 12th Consecutive Year
· Persbericht
15/01 ·
Labcorp to Announce Fourth Quarter Financial Results on February 17, 2026
· Persbericht
15/01 ·
Sonora Quest and Laboratory Sciences of Arizona Announce Jennifer Erickson as CEO-Elect
· Persbericht
14/01 ·
Labcorp Declares Quarterly Dividend
· Persbericht
13/01 ·
Labcorp Expands MRD Testing for Breast, Lung and Colon Cancer Recurrence Risk
· Persbericht
8/01 ·
Quest Diagnostics to Release Fourth Quarter and Full Year 2025 Financial Results on February 10, 2026
· Persbericht
Mijn selecties
Voorbeeldselectie
Je selectie is nog leeg.
Voeg nu effecten toe